Clinical Trial Update: Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial sponsored by Kaiser Permanente evaluating web-based care management for poorly controlled Type 2 Diabetes Mellitus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Kaiser Permanente | Conditions: Type 2 Diabetes Mellitus | NA | Status: WITHDRAWN